Serum level of IL-37 as a modulator in atherosclerosis, correlating its levels with oxidative stress and disease progression
Abstract
Atherosclerosis is a disease where fat, fibrous materials, and calcium build up in the large arteries. This harmful process starts when the inner lining of blood vessels becomes active. This leads to a chain of reactions that cause the blood vessels to narrow and trigger inflammation, eventually resulting in the formation of fatty deposits called atheromatous plaques. Together, these related processes lead to heart problems, which are the main cause of death around the world. T he aim o f this research is to elucidate the function of IL-37 as a modulator in the pathophysiology of atherosclerosis through an examination of its ass o ciation with oxidative stress and the advancement of the disease. This case-control investigation endeavors to quantify IL-37 concentrations in individuals diagnosed with atherosclerosis in comparison to healthy control subjects, thereby evaluating its viability as a biomarker indicative of disease severity and its correlation with markers of oxidative stress. This investigation encompassed a cohort of 50 individuals receiving treatment at the Al-Najaf Center for Cardiac Surgery and Catheter Interve n tion located in Al-Najaf Province, Iraq. A volume of 5 mL of venous blood was procured from each participant, with serum being promptly isolated and subsequently preserved at – 80 °C. The concentrations of serum IL37 and TNF-α were quantified employing a human IL37 & TNF-α ELISA kit. The findings demonstrated that, in comparison to control, atherosclerosis p a tients had significantly higher levels of biochemical variables such as CK-MB, Trop I, MDA, Ox-LDL, and hs-CRP. IL37 and TNF-α mean values showed that patients' levels of IL37 were significantly lower than those of the control group, while TNF-α levels were significantly higher. According to Pea rson correlation, there was a significant negative connection between IL37 and TNF-a, MDA, Ox-LDL, RBS, TC, LDL, urea, CK-MB, TropI, and hs-CRP, whereas there was a negative nonsignificant correlation between IL37 and TG and creatinine. In conclusion, research on the function of IL-37 as a modulator in atheroscl e rosis has shown significant relationships between oxidative stress, IL-37 levels, and the development of the disease.References
Al-Gazally, M. E., Al-Awad, A. S., & Kzar, H. H. (2016). Assessment of antioxidant status in different genotypes/phenotypes at codon 72 of TP53 gene for patients with sporadic colorectal cancer in Babylon province. International Journal of PharmTech Research, 9(3), 280–286.
Aranda-Rivera, A. K., Cruz-Gregorio, A., Arancibia-Hernández, Y. L., Hernández-Cruz, E. Y., & Pedraza-Chaverri, J. (2022). RONS and oxidative stress: An overview of basic concepts. Oxygen, 2(4), 437–478.
Biasillo, G., Cardinale, D., Nhola, L. F., Villarraga, H. R., Jordan, J. H., & Hundley, W. G. (2016). Diagnostic tests in cardio-oncology. In: Herrmann, J. (Ed.). Clinical cardio-oncology. Elsevier. Pp. 313–343.
Chai, M., Zhang, H. T., Zhou, Y. J., Ji, Q. W., Yang, Q., Liu, Y. Y., Zhao, Y. X., Shi, D. M., Liu, W., Yang, L. X., Zhang, L. L., & Liang, J. (2017). Elevated IL-37 levels in the plasma of patients with severe coronary artery calcification. Journal of Geriatric Cardiology, 14(5), 285–291.
Cruz-Gregorio, A., Amezcua-Guerra, L. M., Fisher-Bautista, B., Romero-Beltrán, A., & Fonseca-Camarillo, G. (2024). The protective role of interleukin-37 in cardiovascular diseases through ferroptosis modulation. International Journal of Molecular Sciences, 25(18), 9758.
Faris, J. K., Al-Khamas, A. T. H., Al-Saray, D. A. M., Murad, H. M., & AlWaeli, L. A. J. (2019). Protective effect of bromelain on gentamicin-induced renal damage in rats. Biochemical and Cellular Archives, 19(1), 1297–1301.
Gaggini, M., Gorini, F., & Vassalle, C. (2022). Lipids in atherosclerosis: Pathophysiology and the role of calculated lipid indices in assessing cardiovascular risk in patients with hyperlipidemia. International Journal of Molecular Sciences, 24(1), 75.
Hamad, R. S., & Alalwany, E. A. H. (2024). Comparative histochemical study of pancreas in Eurasian collared dove (Streptopelia decaocto) and buzzard (Buteo buteo vulpinus). Assiut Veterinary Medical Journal, 70(183), 642–652.
Held, C., Hadziosmanovic, N., Aylward, P. E., Hagström, E., Hochman, J. S., Stewart, R. A. H., White, H. D., & Wallentin, L. (2022). Body mass index and association with cardiovascular outcomes in patients with stable coronary heart disease – A STABILITY substudy. Journal of the American Heart Association, 11(3), e023667.
Hou, J.-S., Wang, C.-H., Lai, Y.-H., Kuo, C.-H., Lin, Y.-L., Hsu, B.-G., & Tsai, J.-P. (2020). Serum malondialdehyde-modified low-density lipoprotein is a risk factor for central arterial stiffness in maintenance hemodialysis patients. Nutrients, 12(7), 2160.
Huang, J., Hou, F. L., Zhang, A. Y., & Li, Z. L. (2016). Protective effect of the polarity of macrophages regulated by IL-37 on atherosclerosis. Genetics and Molecular Research, 15(2), 15027616.
Hung, T., Jhan, J.-Y., Lin, J.-H., Yang, K.-T., Hsu, B.-G., & Chang, J.-C. (2023). Serum malondialdehyde-oxidized low-density lipoprotein level is associated with arterial stiffness by cardio-ankle vascular index in coronary artery bypass graft patients. Journal of Clinical Medicine, 12(13), 4191.
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022). Pathophysiology of atherosclerosis. International Journal of Molecular Sciences, 23(6), 3346.
Jin, S., Liu, J., Jia, Y., Sun, C., & Na, L. (2024). Temporal relationships between blood glucose, lipids and BMI, and their impacts on atherosclerosis: A prospective cohort study. BMJ Open, 14(6), e079521.
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023). Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Archives of Toxicology, 97(10), 2499–2574.
Khaki-Khatibi, F., & Mahmoodi, N. (2016). Association of OX-LDL and MDA serum level with extent of coronary artery disease. Alborz University Medical Journal, 5(4), 229–235.
Law, C. C., Puranik, R., Fan, J., Fei, J., Hambly, B. D., & Bao, S. (2021). Clinical implications of IL-32, IL-34 and IL-37 in atherosclerosis: Speculative role in cardiovascular manifestations of COVID-19. Frontiers in Cardiovascular Medicine, 8, 630767.
Li, H., Shen, C., Chen, B., Du, J., Peng, B., Wang, W., Chi, F., Dong, X., Huang, Z., & Yang, C. (2019). Interleukin 37 is increased in peripheral blood mononuclear cells of coronary heart disease patients and inhibits the inflammatory reaction. Molecular Medicine Reports, 21(1), 151–160.
Li, X., Yan, B., Du, J., Xu, S., Liu, L., Pan, C., Kang, X., & Zhu, S. (2022). Recent advances in progresses and prospects of IL-37 in central nervous system diseases. Brain Sciences, 12(6), 723.
Marza, A. D., Murad, H. M., Ali, M. A., Faris, J. K., & Khudhair, A. S. (2020). Berberine effects on liver toxicity induced by oxytetracycline in albino rats. Biochemical and Cellular Archives, 20(S2), 3411–3417.
Naseem, S., Sun, L., & Qiu, J. (2024). Stress granules in atherosclerosis: Insights and therapeutic opportunities. Current Problems in Cardiology, 49(10), 102760.
Neamah, G. A. K., Alalwany, E. A. hamza, Rabee, F. B., Jasim, A. M., Abukhomra, A. S., & Abukhomra, A. S. (2024). Histopathological detection of the protective role of hydroxytyrosol against the adverse effect of azithromycin in rats. Advancements in Life Sciences, 11(2), 386–391.
Nold-Petry, C. A., Lo, C. Y., Rudloff, I., Elgass, K. D., Li, S., Gantier, M. P., Lotz-Havla, A. S., Gersting, S. W., Cho, S. X., Lao, J. C., Ellisdon, A. M., Rotter, B., Azam, T., Mangan, N. E., Rossello, F. J., Whisstock, J. C., Bufler, P., Garlanda, C., Mantovani, A., … Nold, M. F. (2015). IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nature Immunology, 16(4), 354–365.
Poznyak, A. V., Nikiforov, N. G., Markin, A. M., Kashirskikh, D. A., Myasoedova, V. A., Gerasimova, E. V., & Orekhov, A. N. (2021). Overview of OxLDL and its impact on cardiovascular health: Focus on atherosclerosis. Frontiers in Pharmacology, 11, 613780.
Rafiei, A., Ahmadi, R., Kazemian, S., Rahimzadeh-Fallah, T., Mohammad-Rezaei, M., Azadegan-Dehkordi, F., Sanami, S., Mirzaei, Y., Aghaei, F., & Bagheri, N. (2022). Serum levels of IL-37 and correlation with inflammatory cytokines and clinical outcomes in patients with coronary artery disease. Journal of Investigative Medicine, 70(8), 1720–1727.
Rathore, A., Pareek, U., & Sharma, A. (2016). A study of high-sensitivity C-reactive protein and trop-T in patients with coronary artery disease. International Journal of Research in Medical Sciences, 4(4), 1051–1055.
Rudloff, I., Cho, S. X., Lao, J. C., Ngo, D., McKenzie, M., Nold-Petry, C. A., & Nold, M. F. (2016). Monocytes and dendritic cells are the primary sources of interleukin 37 in human immune cells. Journal of Leukocyte Biology, 101(4), 901–911.
Salekeen, R., Haider, A. N., Akhter, F., Billah, M. M., Islam, M. E., & Didarul Islam, K. M. (2022). Lipid oxidation in pathophysiology of atherosclerosis: Current understanding and therapeutic strategies. International Journal of Cardiology Cardiovascular Risk and Prevention, 14, 200143.
Song, J., Farris, D., Ariza, P., Moorjani, S., Varghese, M., Blin, M., Chen, J., Tyrrell, D., Zhang, M., Singer, K., Salmon, M., & Goldstein, D. R. (2023). Age‐associated adipose tissue inflammation promotes monocyte chemotaxis and enhances atherosclerosis. Aging Cell, 22(2), e13783.
Srikrishna, R., Ramesh, S. T., & Girishbabu, R. J. (2015). Study of high sensitive-CRP and cardiac marker enzymes in acute coronary syndrome. Journal of Krishna Institute of Medical Sciences, 4(2), 107–113.
Su, Z., & Tao, X. (2021). Current understanding of IL-37 in human health and disease. Frontiers in Immunology, 12, 696605.
Tyrrell, D. J., & Goldstein, D. R. (2020). Ageing and atherosclerosis: Vascular intrinsic and extrinsic factors and potential role of IL-6. Nature Reviews Cardiology, 18(1), 58–68.
Venuraju, S. M., Jeevarethinam, A., Mehta, V. S., Cohen, M., Darko, D. A., Nair, D., Rakhit, R., Nilsson, J., & Lahiri, A. (2022). Reduced incidence of severe coronary atherosclerosis in obese subjects with type 2 diabetes – an obesity paradox? The International Journal of Cardiodiabetes, 1(2), 58–64.
Verma, A., Soni, Y., & Saxena, R. (2016). Study of serum lipid profile level in coronary artery disease patients. International Journal of Medical Research Professionals, 2(2), 225–227.
Xu, J., Han, X., Xia, N., Zhao, Q., & Cheng, Z. (2023). IL-37 suppresses macrophage ferroptosis to attenuate diabetic atherosclerosis via the NRF2 pathway. Experimental and Therapeutic Medicine, 25(6), 289.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
